Sensei Biotherapeutics Inc
NASDAQ:SNSE
Sensei Biotherapeutics Inc
NASDAQ:SNSE
Price:
30.53
USD
-3.72%
Market Closed
Market Cap:
$38.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sensei Biotherapeutics Inc
NASDAQ:SNSE
|
US |
|
K
|
Kim Heng Ltd
SGX:5G2
|
SG |
|
Cosmo Energy Holdings Co Ltd
TSE:5021
|
JP |
|
U
|
United Palm Oil Industry PCL
SET:UPOIC
|
TH |
|
Northeast Securities Co Ltd
SZSE:000686
|
CN |
|
Physicians Realty Trust
NYSE:DOC
|
US |
|
N
|
Nexalin Technology Inc
NASDAQ:NXL
|
US |
|
TAL Education Group
NYSE:TAL
|
CN |
|
Domacom Australia Ltd
ASX:DCL
|
AU |
|
R
|
Royal Unibrew A/S
CSE:RBREW
|
DK |
|
CHAPTERS Group AG
XETRA:CHG
|
DE |
|
I
|
Isu Chemical Co Ltd
KRX:005950
|
KR |
|
Mettler-Toledo International Inc
NYSE:MTD
|
US |
|
Quince Therapeutics Inc
NASDAQ:QNCX
|
US |
|
S
|
Sicily By Car SpA
MIL:SBC
|
IT |
|
Southwestern Energy Co
NYSE:SWN
|
US |
|
Crescent Biopharma Inc (Pre-Reincorporation)
NASDAQ:CBIO
|
US |
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
CN |
Cash Flow Statement
Cash Flow Statement
Sensei Biotherapeutics Inc
Sensei Biotherapeutics Inc
Currency: USD
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||
| Net Income |
(26)
|
(22)
|
(20)
|
(23)
|
(28)
|
(33)
|
(37)
|
(41)
|
(42)
|
(46)
|
(49)
|
(46)
|
(45)
|
(39)
|
(34)
|
(32)
|
(30)
|
(30)
|
(30)
|
(29)
|
(27)
|
(24)
|
(21)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
3
|
4
|
6
|
6
|
6
|
5
|
5
|
6
|
6
|
5
|
5
|
4
|
4
|
4
|
4
|
3
|
2
|
2
|
1
|
1
|
|
| Other Non-Cash Items |
6
|
6
|
3
|
3
|
4
|
5
|
6
|
6
|
6
|
7
|
7
|
7
|
6
|
5
|
5
|
5
|
5
|
5
|
5
|
4
|
3
|
3
|
2
|
|
| Change in Working Capital |
2
|
(1)
|
(0)
|
(2)
|
(2)
|
2
|
0
|
4
|
(2)
|
0
|
1
|
(2)
|
0
|
(3)
|
(4)
|
(3)
|
(1)
|
(1)
|
(0)
|
0
|
(1)
|
(2)
|
(2)
|
|
| Cash from Operating Activities |
(18)
N/A
|
(17)
+6%
|
(18)
-6%
|
(22)
-24%
|
(25)
-15%
|
(25)
+1%
|
(30)
-21%
|
(30)
+0%
|
(36)
-19%
|
(37)
-3%
|
(39)
-5%
|
(40)
-3%
|
(38)
+6%
|
(35)
+6%
|
(32)
+10%
|
(28)
+13%
|
(24)
+13%
|
(25)
-3%
|
(25)
+1%
|
(24)
+2%
|
(24)
0%
|
(22)
+8%
|
(20)
+9%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(0)
|
(0)
|
(0)
|
0
|
(147)
|
(147)
|
(141)
|
(129)
|
32
|
40
|
50
|
41
|
47
|
46
|
39
|
42
|
29
|
34
|
23
|
24
|
26
|
15
|
20
|
|
| Cash from Investing Activities |
(0)
N/A
|
(1)
-277%
|
(1)
-24%
|
(2)
-31%
|
(149)
-8 020%
|
(149)
+0%
|
(143)
+4%
|
(130)
+9%
|
31
N/A
|
40
+29%
|
50
+26%
|
40
-20%
|
46
+16%
|
46
0%
|
38
-17%
|
42
+9%
|
29
-30%
|
34
+16%
|
22
-34%
|
24
+6%
|
26
+8%
|
15
-43%
|
20
+36%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||
| Net Issuance of Common Stock |
11
|
19
|
37
|
191
|
191
|
182
|
164
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(10)
|
(10)
|
0
|
(3)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
9
|
2
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other |
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
19
N/A
|
21
+10%
|
35
+67%
|
189
+433%
|
188
0%
|
180
-5%
|
164
-9%
|
(0)
N/A
|
(0)
-550%
|
(0)
-115%
|
(0)
-4%
|
(1)
-131%
|
(9)
-1 169%
|
(11)
-28%
|
(11)
-3%
|
(11)
+0%
|
(3)
+70%
|
(1)
+69%
|
(1)
+23%
|
(1)
-1%
|
(1)
+2%
|
(1)
+7%
|
(1)
+11%
|
|
| Change in Cash | ||||||||||||||||||||||||
| Net Change in Cash |
1
N/A
|
3
+178%
|
16
+378%
|
165
+910%
|
14
-92%
|
6
-58%
|
(9)
N/A
|
(161)
-1 602%
|
(6)
+96%
|
2
N/A
|
11
+454%
|
(1)
N/A
|
0
N/A
|
(0)
N/A
|
(5)
-3 887%
|
3
N/A
|
2
-42%
|
8
+367%
|
(3)
N/A
|
(1)
+64%
|
1
N/A
|
(9)
N/A
|
(1)
+85%
|
|
| Free Cash Flow | ||||||||||||||||||||||||
| Free Cash Flow |
(18)
N/A
|
(18)
+2%
|
(19)
-7%
|
(24)
-25%
|
(28)
-16%
|
(27)
+2%
|
(32)
-20%
|
(32)
+2%
|
(37)
-17%
|
(38)
-3%
|
(39)
-3%
|
(40)
-3%
|
(38)
+6%
|
(36)
+6%
|
(32)
+10%
|
(28)
+13%
|
(24)
+13%
|
(25)
-3%
|
(25)
+1%
|
(24)
+2%
|
(24)
0%
|
(22)
+8%
|
(20)
+9%
|
|
Switch to:
Switch to:
See Also
Discover More
